Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
30 January 2023 |
Main ID: |
NCT03771430 |
Date of registration:
|
12/11/2018 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
A Multidisciplinary Intervention in Total Knee Arthroplasty
MultiKnee |
Scientific title:
|
A Multidisciplinary Intervention in Total Knee Arthroplasty - a Multicenter, Randomized Controlled Trial in OA Patients (The MultiKnee Trial) |
Date of first enrolment:
|
August 28, 2019 |
Target sample size:
|
282 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03771430 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Norway
| | | | | | | |
Contacts
|
Name:
|
Maren F Lindberg, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Lovisenberg Diakonale Hospital/University of Oslo |
|
Name:
|
Maren Falch Lindberg, PhD |
Address:
|
|
Telephone:
|
+4794815762 |
Email:
|
mfli@lds.no |
Affiliation:
|
|
|
Name:
|
Kari Indrekvam, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Haukeland University Hospital - Kysthospitalet Hagevik/University of Bergen |
|
Name:
|
Arild Aamodt, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Lovisenberg Diakonale Hospital |
|
Name:
|
Anners Lerdal, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Lovisenberg Diaconal Hospital, University of Oslo |
|
Name:
|
Stig Heir, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Martina Hansens Hospital |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Scheduled for TKA for OA at Lovisenberg, Oslo; Martina Hansen, Bærum, or Coastal
Hospital Hagevik, Bergen
2. Age 18 - 79 years
3. ASA grade 1-3
4. KL grade 3 or 4
5. BMI<40
6. Able to read and write in Norwegian
Exclusion Criteria:
- Diagnosis of dementia or sero-positive rheumatic disease
- Previously undergone uni or patellofemoral prosthesis in the index knee
- Large axis deviation or instability requiring use of hinged implants
- Scheduled for unicompartmental arthroplasty or revision surgery
Age minimum:
18 Years
Age maximum:
79 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Osteoarthritis; Primary
|
Degenerative Joint Disease of Knee
|
Intervention(s)
|
Behavioral: Osteoarthritis education, exercise and CBT
|
Procedure: Total Knee Arthroplasty
|
Primary Outcome(s)
|
Change in the knee injury and osteoarthritis score (KOOS) pain subscale
[Time Frame: Before randomization, 12 months after treatment start. Also measured at 3, 6, and 24 months after treatment start.12 months after treatment start will be the primary outcome.]
|
Secondary Outcome(s)
|
EuroQol-5D-5L
[Time Frame: Before randomization. 3, 6, 12 and 24 months following treatment start]
|
The Forgotten Joint Score
[Time Frame: Before randomization. 3, 6, 12 and 24 months following treatment start]
|
Brief Pain inventory
[Time Frame: Before randomization. 3, 6, 12 and 24 months following treatment start]
|
Pain Catastrophizing Scale
[Time Frame: Before randomization. 3, 6, 12 and 24 months following treatment start]
|
Patient-acceptable symptom state, perceived treatment failure.
[Time Frame: At 3, 6, 12 and 24 months following treatment start.]
|
Knee injury and osteoarthritis score (KOOS) subscores: Other symptoms, activities of daily living (ADL), function in sport and recreation, and knee-related quality of life (QOL)
[Time Frame: Before randomization. 3, 6, 12 and 24 months following treatment start]
|
Adverse events/serious adverse events
[Time Frame: From treatment start until 24 months following treatment start.]
|
Global perceived effect
[Time Frame: At 3, 6, 12 and 24 months following treatment start.]
|
The 30 second sit to stand test
[Time Frame: Before treatment start. 3, 6, 12 and 24 months following treatment start]
|
Secondary ID(s)
|
MultiKnee Trial
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|